Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
CrossRef Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease Sheng Lyu, Jiani Yang, Xin Xin, Qinmei Sun, Beiyu Cai, Xin Wang, Ziming An, Jian Sun, Yiyang Hu, Lei Shi, Qin Feng, Xiaojun Gou BMC Gastroenterology .2025;[Epub] CrossRef Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies Claudia Reytor-Gonzlez, Daniel Simancas-Racines, Martn Campuzano-Donoso, Janeth Castano Jimenez, Nthaly Mercedes Romn-Galeano, Gerardo Sarno, Evelyn Frias-Toral Food and Agricultural Immunology .2025;[Epub] CrossRef Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 20012018 Zhengjin Wang, Zhangxin Chen, Hanxu Zhuang Frontiers in Nutrition .2025;[Epub] CrossRef Anthropometric Measures and Mortality Risk in Individuals With Metabolic DysfunctionAssociated Steatotic Liver Disease (MASLD): A PopulationBased Cohort Study Yee Hui Yeo, Yixuan Zhu, Jingli Gao, Shanghao Liu, Wenjing Ni, Fajuan Rui, Xue Bai, Nan Geng, Rui Jin, Elizabeth K
Starting in 2026, Michigan will start to see individuals who will have exhausted their benefits
MOTS-C has been investigated for its interaction with mitochondrial signaling networks and cellular metabolic communication mechanisms
They are primarily used to manage Type 2 diabetes and aid in weight loss by promoting insulin release, inhibiting glucagon, slowing gastric emptying, and signaling satiety
US$ 29.01
US$ 23.80
US$ 22.13
US$ 28.52
